HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-JAN-13 4IWP TITLE CRYSTAL STRUCTURE AND MECHANISM OF ACTIVATION OF TBK1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE TBK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NF-KAPPA-B-ACTIVATING KINASE, T2K, TANK-BINDING KINASE 1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NAK, TBK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.PANNE,A.LARABI REVDAT 3 28-FEB-24 4IWP 1 REMARK SEQADV REVDAT 2 22-MAY-13 4IWP 1 JRNL REVDAT 1 13-MAR-13 4IWP 0 JRNL AUTH A.LARABI,J.M.DEVOS,S.L.NG,M.H.NANAO,A.ROUND,T.MANIATIS, JRNL AUTH 2 D.PANNE JRNL TITL CRYSTAL STRUCTURE AND MECHANISM OF ACTIVATION OF JRNL TITL 2 TANK-BINDING KINASE 1. JRNL REF CELL REP V. 3 734 2013 JRNL REFN ESSN 2211-1247 JRNL PMID 23453971 JRNL DOI 10.1016/J.CELREP.2013.01.034 REMARK 2 REMARK 2 RESOLUTION. 3.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.1_1168 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 17412 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.283 REMARK 3 R VALUE (WORKING SET) : 0.280 REMARK 3 FREE R VALUE : 0.335 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 871 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.5159 - 5.5677 1.00 2879 152 0.2417 0.2846 REMARK 3 2 5.5677 - 4.4202 1.00 2762 145 0.2804 0.3361 REMARK 3 3 4.4202 - 3.8617 1.00 2759 146 0.2927 0.3487 REMARK 3 4 3.8617 - 3.5087 1.00 2730 143 0.3179 0.3761 REMARK 3 5 3.5087 - 3.2573 1.00 2730 144 0.3389 0.4402 REMARK 3 6 3.2573 - 3.0653 0.98 2681 141 0.3710 0.4419 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.590 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 40.710 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 105.4 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 123.8 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 5203 REMARK 3 ANGLE : 0.509 7025 REMARK 3 CHIRALITY : 0.036 778 REMARK 3 PLANARITY : 0.002 895 REMARK 3 DIHEDRAL : 11.860 1961 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4IWP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077304. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.28 REMARK 200 MONOCHROMATOR : DIAMOND (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17416 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% PEG6000, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.57333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.78667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 28.78667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.57333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 62340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 165 REMARK 465 ASP A 166 REMARK 465 ASP A 167 REMARK 465 GLU A 168 REMARK 465 GLN A 169 REMARK 465 PHE A 170 REMARK 465 VAL A 171 REMARK 465 ALA A 172 REMARK 465 LEU A 173 REMARK 465 TYR A 174 REMARK 465 ARG A 187 REMARK 465 ALA A 188 REMARK 465 VAL A 189 REMARK 465 LEU A 190 REMARK 465 ARG A 191 REMARK 465 LYS A 192 REMARK 465 ASP A 193 REMARK 465 HIS A 194 REMARK 465 GLN A 195 REMARK 465 LYS A 196 REMARK 465 LYS A 197 REMARK 465 TYR A 198 REMARK 465 GLU A 483 REMARK 465 LYS A 484 REMARK 465 LEU A 485 REMARK 465 MET A 486 REMARK 465 LYS A 487 REMARK 465 ILE A 488 REMARK 465 ASN A 489 REMARK 465 LEU A 490 REMARK 465 GLU A 491 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 42 75.31 54.12 REMARK 500 SER A 44 -51.36 -143.69 REMARK 500 LEU A 46 -87.66 -102.78 REMARK 500 HIS A 133 -65.46 -97.28 REMARK 500 ARG A 134 -12.98 67.49 REMARK 500 THR A 156 -56.21 -134.43 REMARK 500 ARG A 228 -143.46 -139.74 REMARK 500 LYS A 241 58.72 32.83 REMARK 500 SER A 243 -127.61 51.07 REMARK 500 ASP A 407 109.31 -49.79 REMARK 500 SER A 531 -2.25 65.67 REMARK 500 GLN A 539 -55.03 -131.57 REMARK 500 ARG A 573 -24.20 66.19 REMARK 500 GLU A 604 -59.70 -124.23 REMARK 500 TYR A 650 -72.56 -99.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BX7 A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4IW0 RELATED DB: PDB REMARK 900 RELATED ID: 4IWO RELATED DB: PDB REMARK 900 RELATED ID: 4IWQ RELATED DB: PDB DBREF 4IWP A 2 657 UNP Q9UHD2 TBK1_HUMAN 2 657 SEQADV 4IWP ALA A -1 UNP Q9UHD2 EXPRESSION TAG SEQADV 4IWP MET A 0 UNP Q9UHD2 EXPRESSION TAG SEQADV 4IWP GLY A 1 UNP Q9UHD2 EXPRESSION TAG SEQADV 4IWP ALA A 172 UNP Q9UHD2 SER 172 ENGINEERED MUTATION SEQRES 1 A 659 ALA MET GLY GLN SER THR SER ASN HIS LEU TRP LEU LEU SEQRES 2 A 659 SER ASP ILE LEU GLY GLN GLY ALA THR ALA ASN VAL PHE SEQRES 3 A 659 ARG GLY ARG HIS LYS LYS THR GLY ASP LEU PHE ALA ILE SEQRES 4 A 659 LYS VAL PHE ASN ASN ILE SER PHE LEU ARG PRO VAL ASP SEQRES 5 A 659 VAL GLN MET ARG GLU PHE GLU VAL LEU LYS LYS LEU ASN SEQRES 6 A 659 HIS LYS ASN ILE VAL LYS LEU PHE ALA ILE GLU GLU GLU SEQRES 7 A 659 THR THR THR ARG HIS LYS VAL LEU ILE MET GLU PHE CYS SEQRES 8 A 659 PRO CYS GLY SER LEU TYR THR VAL LEU GLU GLU PRO SER SEQRES 9 A 659 ASN ALA TYR GLY LEU PRO GLU SER GLU PHE LEU ILE VAL SEQRES 10 A 659 LEU ARG ASP VAL VAL GLY GLY MET ASN HIS LEU ARG GLU SEQRES 11 A 659 ASN GLY ILE VAL HIS ARG ASP ILE LYS PRO GLY ASN ILE SEQRES 12 A 659 MET ARG VAL ILE GLY GLU ASP GLY GLN SER VAL TYR LYS SEQRES 13 A 659 LEU THR ASP PHE GLY ALA ALA ARG GLU LEU GLU ASP ASP SEQRES 14 A 659 GLU GLN PHE VAL ALA LEU TYR GLY THR GLU GLU TYR LEU SEQRES 15 A 659 HIS PRO ASP MET TYR GLU ARG ALA VAL LEU ARG LYS ASP SEQRES 16 A 659 HIS GLN LYS LYS TYR GLY ALA THR VAL ASP LEU TRP SER SEQRES 17 A 659 ILE GLY VAL THR PHE TYR HIS ALA ALA THR GLY SER LEU SEQRES 18 A 659 PRO PHE ARG PRO PHE GLU GLY PRO ARG ARG ASN LYS GLU SEQRES 19 A 659 VAL MET TYR LYS ILE ILE THR GLY LYS PRO SER GLY ALA SEQRES 20 A 659 ILE SER GLY VAL GLN LYS ALA GLU ASN GLY PRO ILE ASP SEQRES 21 A 659 TRP SER GLY ASP MET PRO VAL SER CYS SER LEU SER ARG SEQRES 22 A 659 GLY LEU GLN VAL LEU LEU THR PRO VAL LEU ALA ASN ILE SEQRES 23 A 659 LEU GLU ALA ASP GLN GLU LYS CYS TRP GLY PHE ASP GLN SEQRES 24 A 659 PHE PHE ALA GLU THR SER ASP ILE LEU HIS ARG MET VAL SEQRES 25 A 659 ILE HIS VAL PHE SER LEU GLN GLN MET THR ALA HIS LYS SEQRES 26 A 659 ILE TYR ILE HIS SER TYR ASN THR ALA THR ILE PHE HIS SEQRES 27 A 659 GLU LEU VAL TYR LYS GLN THR LYS ILE ILE SER SER ASN SEQRES 28 A 659 GLN GLU LEU ILE TYR GLU GLY ARG ARG LEU VAL LEU GLU SEQRES 29 A 659 PRO GLY ARG LEU ALA GLN HIS PHE PRO LYS THR THR GLU SEQRES 30 A 659 GLU ASN PRO ILE PHE VAL VAL SER ARG GLU PRO LEU ASN SEQRES 31 A 659 THR ILE GLY LEU ILE TYR GLU LYS ILE SER LEU PRO LYS SEQRES 32 A 659 VAL HIS PRO ARG TYR ASP LEU ASP GLY ASP ALA SER MET SEQRES 33 A 659 ALA LYS ALA ILE THR GLY VAL VAL CYS TYR ALA CYS ARG SEQRES 34 A 659 ILE ALA SER THR LEU LEU LEU TYR GLN GLU LEU MET ARG SEQRES 35 A 659 LYS GLY ILE ARG TRP LEU ILE GLU LEU ILE LYS ASP ASP SEQRES 36 A 659 TYR ASN GLU THR VAL HIS LYS LYS THR GLU VAL VAL ILE SEQRES 37 A 659 THR LEU ASP PHE CYS ILE ARG ASN ILE GLU LYS THR VAL SEQRES 38 A 659 LYS VAL TYR GLU LYS LEU MET LYS ILE ASN LEU GLU ALA SEQRES 39 A 659 ALA GLU LEU GLY GLU ILE SER ASP ILE HIS THR LYS LEU SEQRES 40 A 659 LEU ARG LEU SER SER SER GLN GLY THR ILE GLU THR SER SEQRES 41 A 659 LEU GLN ASP ILE ASP SER ARG LEU SER PRO GLY GLY SER SEQRES 42 A 659 LEU ALA ASP ALA TRP ALA HIS GLN GLU GLY THR HIS PRO SEQRES 43 A 659 LYS ASP ARG ASN VAL GLU LYS LEU GLN VAL LEU LEU ASN SEQRES 44 A 659 CYS MET THR GLU ILE TYR TYR GLN PHE LYS LYS ASP LYS SEQRES 45 A 659 ALA GLU ARG ARG LEU ALA TYR ASN GLU GLU GLN ILE HIS SEQRES 46 A 659 LYS PHE ASP LYS GLN LYS LEU TYR TYR HIS ALA THR LYS SEQRES 47 A 659 ALA MET THR HIS PHE THR ASP GLU CYS VAL LYS LYS TYR SEQRES 48 A 659 GLU ALA PHE LEU ASN LYS SER GLU GLU TRP ILE ARG LYS SEQRES 49 A 659 MET LEU HIS LEU ARG LYS GLN LEU LEU SER LEU THR ASN SEQRES 50 A 659 GLN CYS PHE ASP ILE GLU GLU GLU VAL SER LYS TYR GLN SEQRES 51 A 659 GLU TYR THR ASN GLU LEU GLN GLU THR HET BX7 A 701 34 HETNAM BX7 N-(3-{[5-IODO-4-({3-[(THIOPHEN-2-YLCARBONYL) HETNAM 2 BX7 AMINO]PROPYL}AMINO)PYRIMIDIN-2-YL]AMINO}PHENYL) HETNAM 3 BX7 PYRROLIDINE-1-CARBOXAMIDE FORMUL 2 BX7 C23 H26 I N7 O2 S HELIX 1 1 ASP A 50 LEU A 62 1 13 HELIX 2 2 SER A 93 GLU A 99 1 7 HELIX 3 3 GLU A 100 ALA A 104 5 5 HELIX 4 4 PRO A 108 ASN A 129 1 22 HELIX 5 5 HIS A 181 GLU A 186 1 6 HELIX 6 6 ALA A 200 GLY A 217 1 18 HELIX 7 7 LYS A 231 LYS A 241 1 11 HELIX 8 8 SER A 270 LEU A 285 1 16 HELIX 9 9 GLY A 294 ARG A 308 1 15 HELIX 10 10 THR A 331 LYS A 344 1 14 HELIX 11 11 ILE A 346 GLN A 350 5 5 HELIX 12 12 LEU A 366 PHE A 370 5 5 HELIX 13 13 ASP A 407 VAL A 479 1 73 HELIX 14 14 ALA A 493 SER A 527 1 35 HELIX 15 15 ALA A 533 ALA A 537 5 5 HELIX 16 16 ARG A 547 ARG A 573 1 27 HELIX 17 17 ALA A 576 GLU A 604 1 29 HELIX 18 18 GLU A 604 ILE A 640 1 37 SHEET 1 A 5 HIS A 7 GLN A 17 0 SHEET 2 A 5 ALA A 21 HIS A 28 -1 O VAL A 23 N GLY A 16 SHEET 3 A 5 LEU A 34 PHE A 40 -1 O VAL A 39 N ASN A 22 SHEET 4 A 5 LYS A 82 GLU A 87 -1 O LEU A 84 N LYS A 38 SHEET 5 A 5 LEU A 70 GLU A 75 -1 N PHE A 71 O ILE A 85 SHEET 1 B 2 ILE A 141 ILE A 145 0 SHEET 2 B 2 SER A 151 LEU A 155 -1 O VAL A 152 N VAL A 144 SHEET 1 C 3 PHE A 221 ARG A 222 0 SHEET 2 C 3 SER A 247 VAL A 249 1 O GLY A 248 N ARG A 222 SHEET 3 C 3 ASP A 258 SER A 260 -1 O ASP A 258 N VAL A 249 SHEET 1 D 5 THR A 320 ILE A 326 0 SHEET 2 D 5 MET A 309 SER A 315 -1 N MET A 309 O ILE A 326 SHEET 3 D 5 ILE A 379 VAL A 382 1 O ILE A 379 N HIS A 312 SHEET 4 D 5 GLU A 351 TYR A 354 -1 N GLU A 351 O VAL A 382 SHEET 5 D 5 ARG A 357 ARG A 358 -1 O ARG A 357 N TYR A 354 SITE 1 AC1 13 ILE A 14 LEU A 15 GLY A 18 ALA A 21 SITE 2 AC1 13 VAL A 23 ALA A 36 LYS A 38 GLU A 87 SITE 3 AC1 13 CYS A 89 GLY A 92 MET A 142 THR A 156 SITE 4 AC1 13 ASP A 157 CRYST1 135.410 135.410 86.360 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007385 0.004264 0.000000 0.00000 SCALE2 0.000000 0.008527 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011579 0.00000